Princeton Alpha Management’s West Pharmaceutical WST Stock Holding History

Princeton Alpha Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,595	Closed	-$375K	–	386
2017 Q1	$375K	Buy	+4,595	New	+$384K	0.13%	283
2016 Q4	–	Sell	-5,243	Closed	-$391K	–	894
2016 Q3	$391K	Buy	+5,243	New	+$416K	0.07%	398
2014 Q3	–	Sell	-5,875	Closed	-$248K	–	846
2014 Q2	$248K	Sell	5,875 -1,634	-22%	-$70K	0.05%	511
2014 Q1	$331K	Buy	+7,509	New	+$353K	0.1%	318

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Princeton Alpha Management's WST Position: Q2 2017 in Review

Princeton Alpha Management sold out of West Pharmaceutical (WST) in Q2 2017, closing a stake of 4,595 shares — an estimated $375K sold.

Princeton Alpha Management first reported a position in WST in Q1 2014 and held it in 4 quarters. The position peaked at $391K in Q3 2016. 310 funds tracked by Wall St. Rank hold WST as of Q2 2017.

Princeton Alpha Management reported no remaining West Pharmaceutical position as of Q2 2017 after selling out during the quarter.
Princeton Alpha Management sold 4,595 West Pharmaceutical shares in Q2 2017, an estimated $375K.
Princeton Alpha Management first reported a position in West Pharmaceutical in Q1 2014 and held it in 4 quarters.
Princeton Alpha Management's West Pharmaceutical position peaked at $391K in Q3 2016.
310 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2017.

Based on Princeton Alpha Management's 13F filing for Q2 2017.